<VariationArchive VariationID="521420" VariationName="NM_015338.6(ASXL1):c.4127dup (p.Pro1377fs)" VariationType="Duplication" Accession="VCV000521420" Version="11" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-02-28" DateCreated="2018-04-15" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="512448" VariationID="521420">
      <GeneList>
        <Gene Symbol="ASXL1" FullName="ASXL transcriptional regulator 1" GeneID="171023" HGNC_ID="HGNC:18318" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>20q11.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="32358331" stop="32439319" display_start="32358331" display_stop="32439319" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="30946146" stop="31027121" display_start="30946146" display_stop="31027121" Strand="+" />
          </Location>
          <OMIM>612990</OMIM>
          <Haploinsufficiency last_evaluated="2013-03-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ASXL1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2013-03-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ASXL1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_015338.6(ASXL1):c.4127dup (p.Pro1377fs)</Name>
      <CanonicalSPDI>NC_000020.11:32436833:GGGGGG:GGGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>20q11.21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="32436833" stop="32436834" display_start="32436833" display_stop="32436834" variantLength="1" positionVCF="32436833" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="31024636" stop="31024637" display_start="31024636" display_stop="31024637" variantLength="1" positionVCF="31024636" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
      </Location>
      <ProteinChange>P1377fs</ProteinChange>
      <ProteinChange>P1316fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_630" sequenceAccession="LRG_630">
            <Expression>LRG_630:g.83496dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015338.5" sequenceAccession="NM_015338" sequenceVersion="5" change="c.4127dupG">
            <Expression>NM_015338.5:c.4127dupG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015338.5" sequenceAccession="NM_015338" sequenceVersion="5" change="c.4127dup">
            <Expression>NM_015338.5:c.4127dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.31024642dup" Assembly="GRCh37">
            <Expression>NC_000020.10:g.31024642dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015338.6" sequenceAccession="NM_015338" sequenceVersion="6" change="c.4127dup" MANESelect="true">
            <Expression>NM_015338.6:c.4127dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_056153.2" sequenceAccession="NP_056153" sequenceVersion="2" change="p.Pro1377fs">
            <Expression>NP_056153.2:p.Pro1377fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.11" sequenceAccession="NC_000020" sequenceVersion="11" change="g.32436839dup" Assembly="GRCh38">
            <Expression>NC_000020.11:g.32436839dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_027868.1" sequenceAccession="NG_027868" sequenceVersion="1" change="g.83496dup">
            <Expression>NG_027868.1:g.83496dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363734.1" sequenceAccession="NM_001363734" sequenceVersion="1" change="c.3944dup">
            <Expression>NM_001363734.1:c.3944dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350663.1" sequenceAccession="NP_001350663" sequenceVersion="1" change="p.Pro1316fs">
            <Expression>NP_001350663.1:p.Pro1316fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA645612978" DB="ClinGen" />
        <XRef Type="rs" ID="1555912897" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_015338.6(ASXL1):c.4127dup (p.Pro1377fs) AND Inborn genetic diseases" Accession="RCV000622437" Version="2">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-12-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_015338.6(ASXL1):c.4127dup (p.Pro1377fs) AND not provided" Accession="RCV001860441" Version="6">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-10-16" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_015338.6(ASXL1):c.4127dup (p.Pro1377fs) AND multiple conditions" Accession="RCV002499012" Version="1">
        <ClassifiedConditionList TraitSetID="19350">
          <ClassifiedCondition DB="MedGen" ID="C0796232">Bohring-Opitz syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3463824">Myelodysplastic syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-03" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-16" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2018-04-15" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16412590</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21706002</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26364555</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31969346</ID>
        </Citation>
        <DescriptionHistory Dated="2022-12-31">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="19350" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1074" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">C-like syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Opitz trigonocephaly-like syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Bohring-Opitz syndrome</ElementValue>
                <XRef ID="MONDO:0011510" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bohring syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BOS syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BOPS</ElementValue>
                <XRef Type="MIM" ID="605039" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Bohring-Opitz syndrome (BOS) is characterized by distinctive facial features and posture, growth failure, variable but usually severe intellectual disability, and variable anomalies. The facial features may include microcephaly or trigonocephaly / prominent (but not fused) metopic ridge, hypotonic facies with full cheeks, synophrys, glabellar and eyelid nevus flammeus (simplex), prominent globes, widely set eyes, palate anomalies, and micrognathia. The BOS posture, which is most striking in early childhood and often becomes less apparent with age, is characterized by flexion at the elbows with ulnar deviation and flexion of the wrists and metacarpophalangeal joints. Feeding difficulties in early childhood, including cyclic vomiting, have a significant impact on overall health; feeding tends to improve with age. Seizures are common and typically responsive to standard epileptic medications. Minor cardiac anomalies and transient bradycardia and apnea may be present. Affected individuals may experience recurrent infections, which also tend to improve with age. Isolated case reports suggest that individuals with BOS are at greater risk for Wilms tumor than the general population, but large-scale epidemiologic studies have not been conducted.</Attribute>
                <XRef ID="NBK481833" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10140" />
                <XRef ID="10140" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29446906</ID>
                <ID Source="BookShelf">NBK481833</ID>
              </Citation>
              <XRef ID="97297" DB="Orphanet" />
              <XRef ID="C0796232" DB="MedGen" />
              <XRef ID="MONDO:0011510" DB="MONDO" />
              <XRef Type="MIM" ID="605039" DB="OMIM" />
            </Trait>
            <Trait ID="16591" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MYELODYSPLASTIC SYNDROME, SUSCEPTIBILITY TO</ElementValue>
                <XRef Type="MIM" ID="614286" DB="OMIM" />
                <XRef Type="Allelic variant" ID="137295.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="137295.0002" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myelodysplastic syndrome, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Myelodysplastic syndrome</ElementValue>
                <XRef ID="Myelodysplastic+syndromes/5021" DB="Genetic Alliance" />
                <XRef ID="MONDO:0018881" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myelodysplastic syndromes</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MDS</ElementValue>
                <XRef Type="MIM" ID="614286" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Myelodysplastic syndrome (MDS) is a heterogeneous group of clonal hematologic stem cell disorders characterized by ineffective hematopoiesis resulting in low blood counts, most commonly anemia, and a risk of progression to acute myeloid leukemia (AML; 601626). Blood smears and bone marrow biopsies show dysplastic changes in myeloid cells, with abnormal proliferation and differentiation of 1 or more lineages (erythroid, myeloid, megakaryocytic). MDS can be subdivided into several categories based on morphologic characteristics, such as low-grade refractory anemia (RA) or high-grade refractory anemia with excess blasts (RAEB). Bone marrow biopsies of some patients show ringed sideroblasts (RARS), which reflects abnormal iron staining in mitochondria surrounding the nucleus of erythrocyte progenitors (summary by Delhommeau et al., 2009 and Papaemmanuil et al., 2011).</Attribute>
                <XRef Type="MIM" ID="614286" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7132" />
                <XRef ID="7132" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="52688" DB="Orphanet" />
              <XRef ID="C3463824" DB="MedGen" />
              <XRef ID="D009190" DB="MeSH" />
              <XRef ID="MONDO:0018881" DB="MONDO" />
              <XRef Type="MIM" ID="614286" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1445799" SubmissionDate="2020-10-09" DateLastUpdated="2023-01-07" DateCreated="2018-04-15">
        <ClinVarSubmissionID localKey="a8833783" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000742005" DateUpdated="2023-01-07" DateCreated="2018-04-15" Type="SCV" Version="3" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-12-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26364555</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16412590</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21706002</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry exome assertion method (8-5-2015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/xlwdlsvu/ambry_exome_assertion_method_8-5-2015_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Caucasian</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
              <FamilyData PedigreeID="a914515" />
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Intellectual disability, severe</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0010864" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Generalized hypotonia</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001290" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Joint hypermobility</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001382" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Scoliosis</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0002650" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Proptosis</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000520" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Low-set ears</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000369" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Global developmental delay</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001263" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Absent speech</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001344" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Muscular hypotonia</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001252" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASXL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015338.5:c.4127dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MeSH" ID="D030342" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>NovelandUpdateExomeDeposit_ExomeProgenyThrough080120</SubmissionName>
          <SubmissionName>exome clinvar deposit 2.18.18</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5465122" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_015338.6:c.4127dup|OMIM:605039;614286" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002806970" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015338.6:c.4127dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605039" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614286" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7802155" SubmissionDate="2023-11-22" DateLastUpdated="2023-11-25" DateCreated="2023-11-25">
        <ClinVarSubmissionID localKey="GDXSV:316218" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV004168073" DateUpdated="2023-11-25" DateCreated="2023-11-25" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASXL1" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:1506502</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015338.5:c.4127dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_236_20231122054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4247055" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="12497913|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002235354" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-02-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31969346</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts the C-terminus of the ASXL1 protein. Other variant(s) that disrupt this region (p.Glu1400*) have been determined to be pathogenic (PMID: 31969346). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. This variant has been observed in individual(s) with clinical features of Bohring-Opitz syndrome (Invitae). ClinVar contains an entry for this variant (Variation ID: 521420). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Pro1377Serfs*3) in the ASXL1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 165 amino acid(s) of the ASXL1 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASXL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000020.10:g.31024636_31024637insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5465122" TraitType="Disease" MappingType="XRef" MappingValue="605039" MappingRef="OMIM">
        <MedGen CUI="C0796232" Name="Bohring-Opitz syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4247055" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445799" TraitType="Disease" MappingType="XRef" MappingValue="D030342" MappingRef="MeSH">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445799" TraitType="Finding" MappingType="Name" MappingValue="Generalized hypotonia" MappingRef="Preferred">
        <MedGen CUI="C1858120" Name="Generalized hypotonia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7802155" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445799" TraitType="Finding" MappingType="Name" MappingValue="Muscular hypotonia" MappingRef="Preferred">
        <MedGen CUI="C0026827" Name="Hypotonia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445799" TraitType="Finding" MappingType="Name" MappingValue="Joint hypermobility" MappingRef="Preferred">
        <MedGen CUI="C1844820" Name="Joint hypermobility" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445799" TraitType="Finding" MappingType="Name" MappingValue="Scoliosis" MappingRef="Preferred">
        <MedGen CUI="C0036439" Name="Scoliosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445799" TraitType="Finding" MappingType="Name" MappingValue="Intellectual disability, severe" MappingRef="Preferred">
        <MedGen CUI="C0036857" Name="Intellectual disability, severe" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445799" TraitType="Finding" MappingType="Name" MappingValue="Global developmental delay" MappingRef="Preferred">
        <MedGen CUI="C0557874" Name="Global developmental delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445799" TraitType="Finding" MappingType="Name" MappingValue="Absent speech" MappingRef="Preferred">
        <MedGen CUI="C1854882" Name="Absent speech" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445799" TraitType="Finding" MappingType="Name" MappingValue="Proptosis" MappingRef="Preferred">
        <MedGen CUI="C0015300" Name="Proptosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5465122" TraitType="Disease" MappingType="XRef" MappingValue="614286" MappingRef="OMIM">
        <MedGen CUI="C3463824" Name="Myelodysplastic syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445799" TraitType="Finding" MappingType="Name" MappingValue="Low-set ears" MappingRef="Preferred">
        <MedGen CUI="C0239234" Name="Low-set ears" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

